9 September
2024
Assura plc
Appointment of
CIO
Assura plc ("Assura" or the
"Company"), the specialist healthcare property investor and
developer, has appointed Steven Noble to the newly created role of
Chief Investment Officer ("CIO") to support the business' short and
long-term growth strategy.
Steven joins the business effective
immediately and will be responsible for implementing Assura's
investment strategy across all healthcare markets, including
delivery of capital recycling initiatives.
Steven was most recently Chief
Investment Officer at Atrato Group, the investment adviser to
Atrato Onsite Energy (ROOF) and Supermarket Income REIT
(SUPR), where he negotiated and executed over £2 billion of
property transactions and played an
important role in taking SUPR from IPO to the FTSE250. Prior roles
include nine years at Lloyds in origination and risk management
with a focus on commercial real estate and KPMG where he qualified
as a chartered accountant.
Jonathan Murphy, Assura CEO, said: "Steven's appointment to the
newly created role of Chief Investment Officer is an important
strategic step for Assura to support our ambitious growth plans.
The UK healthcare crisis continues to worsen with an immense need
for improved access to healthcare services across the country.
These factors are driving demand for infrastructure across an
increasingly diverse range of healthcare markets, to which Assura
is best placed to respond owning to our market position, sector
expertise and capabilities and our strong corporate culture.
Steven's skills and expertise will complement those already within
the Executive Committee to deliver against this demand and our
long-term growth strategy."
Steven Noble, Assura CIO, said: "I'm delighted to be joining Assura at such an exciting time,
with the business strategically positioned to capture the
significant growth opportunities across broader healthcare markets.
The business' recent acquisition of 14 private hospitals and its JV
with USS are a clear indication of the group's ambition and I am
incredibly excited to be part of Assura's next stage of growth. I
look forward to working as part of an exceptionally skilled and
experienced team at the UK's leading listed healthcare property
investor."
- Ends
-
For more information, please
contact:
|
Assura plc
|
Tel: 0161 515 2043
|
|
David Purcell, Investor Relations
Director
|
Email: Investor@assura.co.uk
|
|
FGS
Global
Gordon Simpson
|
Tel: 0207 251 3801
Email: Assura@fgsglobal.com
|
Notes to Editors
Assura plc is the UK's leading
specialist healthcare property investor and developer. Assura
enables better health outcomes through its portfolio of more than
600 healthcare buildings, from which over six million patients are
served.
A UK REIT based in Altrincham,
Assura is a constituent of the FTSE 250 and the EPRA* indices. As
at 31 March 2024, Assura's portfolio was valued at £2.7 billion and
has a strong track record of growing financial returns and
dividends for shareholders.
At Assura we BUILD for health and as
the first FTSE 250 certified B Corp we are committed to keeping ESG
at the heart of our strategy, creating Healthy Environments (E) and
Healthy Communities (S) and maintaining a Healthy Business
(G).
Further information is available
at www.assuraplc.com
*EPRA is a
registered trademark of the European Public Real Estate
Association
Assura plc LEI code: 21380026T19N2Y52XF72
